Nipro (NPRRF) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Nipro FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nipro's Free Cash Flow for the three months ended in Dec. 2023 was $0 Mil. Nipro's Revenue for the three months ended in Dec. 2023 was $1,065 Mil. Therefore, Nipro's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Nipro's current FCF Yield % is 5.04%.

The historical rank and industry rank for Nipro's FCF Margin % or its related term are showing as below:

NPRRF' s FCF Margin % Range Over the Past 10 Years
Min: 1.91 Med: 8.96 Max: 14.51
Current: 1.91

During the past 13 years, the highest FCF Margin % of Nipro was 14.51%. The lowest was 1.91%. And the median was 8.96%.

NPRRF's FCF Margin % is ranked better than
64.12% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -7.14 vs NPRRF: 1.91

Nipro FCF Margin % Historical Data

The historical data trend for Nipro's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro FCF Margin % Chart

Nipro Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

FCF Margin %

Get a 7-Day Free Trial

9.70

8.42

14.51

13.79

1.91

Nipro Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Nipro's FCF Margin %

For the Medical Instruments & Supplies subindustry, Nipro's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nipro's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nipro's FCF Margin % falls into.

Nipro FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nipro's FCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	77.769	/	4078.868
	=	1.91 %

Nipro's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	1064.512
	=	0.00 %

Nipro FCF Margin % Related Terms

Thank you for viewing the detailed overview of Nipro's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nipro (NPRRF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (OTCPK:NPRRF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

8086:Japan

Address

3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510

Website

http://www.nipro.co.jp

Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (NPRRF) Headlines

No Headlines